icd 10 code for chemo induced fatigue

by Prof. Salvador Bauch 9 min read

Neoplastic (malignant) related fatigue
R53. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R53. 0 became effective on October 1, 2021.

What is the ICD 10 code for cancer related fatigue?

Oct 01, 2021 · R53.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R53.0 became effective on October 1, 2021. This is the American ICD-10-CM version of R53.0 - other international versions of ICD-10 R53.0 may differ. Code First. Code First Help.

What are the ICD-10-CM codes for fatigue due to depression?

Oct 01, 2021 · R53.83 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R53.83 became effective on October 1, 2021. This is the American ICD-10-CM version of R53.83 - other international versions of ICD-10 R53.83 may differ.

What is the CPT code for general fatigue?

Mar 14, 2021 · ICD-10 codes. R53.82 – Chronic fatigue; J44.9 – COPD; M25.511 – Right shoulder pain; F41.1 – Generalized anxiety disorder; I10 – Hypertension; F17.220 – chewing tobacco dependence; Fatigue ICD 10 Example – 2. Lisa Perez, 45 year old female visits hospital with her daughter for extreme fatigue. She is undergoing chemotherapy for her left Breast cancer.

What is the code for malaise and fatigue?

R53.0 is a billable diagnosis code used to specify a medical diagnosis of neoplastic (malignant) related fatigue. The code R53.0 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions. The ICD-10-CM code R53.0 might also be used to specify conditions or terms like cancer-related fatigue.

image

What is the ICD-10 code for weakness and fatigue?

ICD-10-CM Code for Other malaise and fatigue R53. 8.

What is the ICD-10-CM code for chemotherapy treatment?

ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .

How do you code adverse effects of chemotherapy?

ICD-10-CM Code for Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter T45. 1X5A.

What does ICD code R53 83 mean?

ICD-10 | Other fatigue (R53. 83)

What is the diagnosis code for chemotherapy?

Encounter for antineoplastic chemotherapy

Z51. 11 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

How do you code chemotherapy?

The ICD-10 code for an evaluation prior to chemotherapy is Z01. 818 (encounter for examinations prior to antineoplastic chemotherapy). Z51. 11 is attached to the billing for the administration of chemotherapy so would not be used by the provider when the patient is going to a hospital-owned infusion center.Mar 15, 2021

What is the ICD-10 code for chemotherapy induced nausea?

Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter. T45. 1X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

What is the ICD-10 code for immunosuppressed due to chemotherapy?

ICD-10 Code ICD-10 Description Assign when immunodeficiency is due to: D84. 821 Immunodeficiency due to drugs Medications that interfere with the immune system. These medications include immunosuppressants, corticosteroids, and chemotherapy.

What is the ICD-10 code for hypomagnesemia?

ICD-10 | Hypomagnesemia (E83. 42)

What is the ICD-10 code for chronic fatigue?

ICD-10 | Chronic fatigue, unspecified (R53. 82)

What is diagnosis code R42?

Dizziness and Giddiness
Code R42 is the diagnosis code used for Dizziness and Giddiness. It is a disorder characterized by a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo).

What is the ICD-10 code for Arthralgias?

Code M25. 50 is the diagnosis code used for Pain in the Unspecified Joint. It falls under the category of Diseases of the musculoskeletal system and connective tissue.

What are the symptoms of fatigue?

Other symptoms may include muscle weakness, fever, sore throat, headache and joint pain.

What is physical fatigue?

Physical fatigue – Person is physically experiencing extreme tiredness and muscle weakness. This makes it difficult to perform daily activities which were done easily before. Mental fatigue – Here the person is unable to concentrate in anything and feels the brain is not working at all.

Is Lisa Perez a smoker?

She is undergoing chemotherapy for her left Breast cancer. She does not have any significant history. She is a non-smoker and non-alcoholic. Daughter states that her mom sleeps for a longer time. She feels difficult to climb stairs.

What is the ICd 10 code for fatigue?

R53.0 is a billable diagnosis code used to specify a medical diagnosis of neoplastic (malignant) related fatigue. The code R53.0 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code R53.0 might also be used to specify conditions or terms like cancer-related fatigue.

Is fatigue a disease?

Fatigue itself is not a disease. Medical problems, treatments, and personal habits can add to fatigue. These include. Taking certain medicines, such as antidepressants, antihistamines, and medicines for nausea and pain. Having medical treatments, like chemotherapy and radiation.

What is the tabular list of diseases and injuries?

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code R53.0:

What is the GEM crosswalk?

The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code R53.0 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.

What is cancer called?

Cancer. Also called: Carcinoma, Malignancy, Neoplasms, Tumor. Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong.

How does cancer start?

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

What is the difference between benign and malignant tumors?

These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body. Cancer is not just one disease but many diseases.

Oncology, solid tumor cancer diagnoses

195.2 Abdominal cavity#N#173.5 Abdominal wall (skin)#N#154.3 Anus (anal)#N#156.9 Biliary tract (cholangiocarcinoma), unspecified site#N#188.9 Bladder, unspecified site#N#233.7 Bladder, in situ#N#191.9 Brain, unspecified site#N#174.9 Breast, female, unspecified site#N#233.0 Breast, in situ (DCIS)#N#175.9 Breast, male, unspecified site#N#162.9 Bronchus, unspecified site#N#180.9 Cervix (cervival), unspecified site#N#233.1 Cervix uteri, in situ#N#170.9 Chondrosarcoma#N#153.9 Colon (colorectal), unspecified site#N#182.0 Endometrium (endometrial)#N#150.9 Esophagus (esophageal), unspecified site#N#170.9 Ewing's sarcoma#N#159.9 Gastrointestinal tract, unspecified site#N#184.9 Genital, female, unspecified site#N#187.9 Genital, male, unspecified site#N#153.9 Intestine (bowel), large, unspecified site#N#152.9 Intestine (bowel), small, unspecified site#N#176.9 Kaposi's Sarcoma, unspecified site#N#189.0 Kidney (renal)#N#155.0 Liver (hepatocellular), primary#N#155.2 Liver, not specified as primary or secondary#N#162.9 Lung (adenocarcinoma/squamous cell carcinoma), unspecified site#N#209.36 Merkel cell carcinoma#N#145.9 Mouth, unspecified site#N#147.9 Nasopharynx, unspecified site#N#170.9 Osteosarcoma#N#183.0 Ovary (ovarian)#N#157.9 Pancreas (pancreatic), unspecified part#N#163.8 Pleura/contiguous sites#N#185 Prostate#N#233.4 Prostate, in situ#N#154.1 Rectum#N#158.0 Retroperitoneum#N#171.9 Rhabdosarcoma#N#142.9 Salivary gland, unspecified site#N#171.9 Sarcoma, connective or soft tissue#N#172.9 Skin, melanoma, unspecified site#N#173.9 Skin, unspecified malignancy, unspecified site#N#151.9 Stomach, unspecified site#N#186.9 Testis (testicular), unspecified site#N#195.1 Thorax#N#193 Thyroid#N#141.9 Tongue, unspecified site#N#199.1 Unknown primary#N#179 Uterus (uterine), unspecified site.

Oncology, hematologic diagnoses

207.00 Acute erythremia & erythroleukemia#N#207.00 Acute lymphoid leukemia (ALL)#N#206.00 Acute monocytic leukemia#N#205.00 Acyte myeloid leukemia (AML)#N#208.00 Acute leukemia, unspecified#N#277.30 E85.9 Amyloidosis#N#208.10 Chronic leukemia, unspecified#N#204.10 Chronic lymphoid leukemia (CLL)#N#206.10 Chronic monocytic leukemia#N#205.10 Chronic myeloid leukemia (CML)#N#202.40 Hairy cell leukemia#N#207.20 Megakaryocytic leukemia#N#273.1 D47.2 Monoclonal gammopathy of undetermined significance (MGUS)#N#203.00 C90.0 [0-2] Multiple myeloma (MM)#N#203.10 C90.1 [0-2] Plasma cell leukemia.

Chemotherapy-related

284.11 Antineoplastic chemotherapy induced pancytopenia#N#285.3 Antineoplastic chemotherapy induced anemia#N#995.29 Complication of chemotherapy#N#999.81 Extravasation of vesicant chemotherapy#N#V07.39 Need for other prophylactic chemotherapy#N#V58.11 Encounter for antineoplastic chemotherapy#N#V66.2 Convalescence following chemotherapy#N#V67.2 Follow-up examination following chemotherapy#N#V87.41 Personal history of antineoplastic chemotherapy.

image